Clinical Trial Update: Genetics in Non-response to Anti-VEGF Treatment in Exudative AMD [Phase 4]

View source ↗

Summary

This entry updates on a Phase 4 clinical trial examining genetic factors linked to non-response to anti-VEGF therapy in exudative age-related macular degenerati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Snippet

Sponsor: University of Cologne | Conditions: Macular Degeneration | Phase 4 | Status: UNKNOWN